Newsroom
-
Mammoth Biosciences Collaborates with GSK Consumer Healthcare to Develop COVID-19 Test Using CRISPR-Based Platform
WebWireLearn More -
Mammoth Biosciences Announces Peer-Reviewed Validation Of Its Rapid, CRISPR-Based COVID-19 Diagnostic
WebWireLearn More -
Mammoth Biosciences Raises $45 Million to Build Next-Generation CRISPR Products For Therapeutics and Diagnostics
WebWireLearn More -
Mammoth Biosciences Licenses 2 UC Patents for CRISPR-Based Diagnostic Platform
Genetic Engineering & Biotechnology NewsLearn More -